Magellan Asset Management Ltd boosted its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 2.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,908,938 shares of the company’s stock after acquiring an additional 258,477 shares during the quarter. HCA Healthcare accounts for 5.3% of Magellan Asset Management Ltd’s portfolio, making the stock its 9th largest position. Magellan Asset Management Ltd’s holdings in HCA Healthcare were worth $1,683,067,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently added to or reduced their stakes in the business. Oregon Public Employees Retirement Fund grew its holdings in shares of HCA Healthcare by 16,494.3% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 11,119,359 shares of the company’s stock worth $89,000 after purchasing an additional 11,052,352 shares during the last quarter. Norges Bank bought a new stake in shares of HCA Healthcare during the fourth quarter worth $359,391,000. Canada Pension Plan Investment Board grew its holdings in shares of HCA Healthcare by 111.5% during the fourth quarter. Canada Pension Plan Investment Board now owns 1,614,102 shares of the company’s stock worth $200,858,000 after purchasing an additional 850,902 shares during the last quarter. Janus Henderson Group PLC grew its holdings in shares of HCA Healthcare by 33.6% during the first quarter. Janus Henderson Group PLC now owns 2,368,547 shares of the company’s stock worth $308,812,000 after purchasing an additional 596,056 shares during the last quarter. Finally, Bank of Nova Scotia grew its holdings in shares of HCA Healthcare by 505.0% during the fourth quarter. Bank of Nova Scotia now owns 557,426 shares of the company’s stock worth $69,368,000 after purchasing an additional 465,293 shares during the last quarter. Hedge funds and other institutional investors own 70.29% of the company’s stock.
HCA Healthcare stock traded down $2.44 during mid-day trading on Wednesday, hitting $125.60. The stock had a trading volume of 61,760 shares, compared to its average volume of 1,793,874. HCA Healthcare Inc has a 12 month low of $101.30 and a 12 month high of $147.42. The stock has a market cap of $42.91 billion, a price-to-earnings ratio of 12.87, a P/E/G ratio of 1.03 and a beta of 0.76.
The business also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Monday, June 3rd will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date is Friday, May 31st. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.38%.
In other HCA Healthcare news, insider Jon M. Foster sold 44,281 shares of the firm’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $122.28, for a total transaction of $5,414,680.68. Following the transaction, the insider now owns 96,052 shares in the company, valued at $11,745,238.56. The sale was disclosed in a document filed with the SEC, which is available through this link. 2.70% of the stock is currently owned by company insiders.
HCA has been the topic of several research analyst reports. Zacks Investment Research upgraded HCA Healthcare from a “hold” rating to a “buy” rating and set a $139.00 target price on the stock in a report on Friday, May 3rd. UBS Group raised their price target on HCA Healthcare from $164.00 to $172.00 and gave the company a “buy” rating in a report on Wednesday, May 1st. Deutsche Bank raised their price target on HCA Healthcare from $160.00 to $165.00 and gave the company a “buy” rating in a report on Wednesday, May 1st. Jefferies Financial Group set a $158.00 price target on HCA Healthcare and gave the company a “buy” rating in a report on Wednesday, April 17th. Finally, ValuEngine cut HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, March 6th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and eighteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $149.00.
TRADEMARK VIOLATION NOTICE: This news story was published by Week Herald and is the property of of Week Herald. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://weekherald.com/2019/06/12/hca-healthcare-inc-nysehca-holdings-lifted-by-magellan-asset-management-ltd.html.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.